Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001387131-21-002074
Filing Date
2021-02-11
Accepted
2021-02-11 14:04:18
Documents
2
Group Members
ALTIUM GROWTH FUND, LPALTIUM GROWTH GP, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13G opnt-sc13ga_123120.htm SC 13G/A 104334
2 JOINT ACQUISITION STATEMENT ex-1.htm EX-1 13558
  Complete submission text file 0001387131-21-002074.txt   119670
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Subject) CIK: 0001385508 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90404 | Film No.: 21618610
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 W 57 ST FL20 NEW YORK NY 10019
Business Address 152 W 57 ST FL20 NEW YORK NY 10019 2124842711
Altium Capital Management LP (Filed by) CIK: 0001746382 (see all company filings)

EIN.: 822066653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A